Skin-sparing mastectomy for the treatment of breast cancer

Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
JOHN WILEY AND SONS LTD
Citação
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, v.2023, n.3, article ID CD010993, p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Skin-sparing mastectomy (SSM) is a surgical technique that aims to maximize skin preservation, facilitate breast reconstruction, and improve cosmetic outcomes. Despite its use in clinical practice, the benefits and harms related to SSM are not well established. Objectives: To assess the effectiveness and safety of skin-sparing mastectomy for the treatment of breast cancer. Search methods: We searched Cochrane Breast Cancer's Specialized Register, CENTRAL, MEDLINE, Embase, LILACS, the World Health Organization's International Clinical Trials Registry Platform (WHO ICTRP), and ClinicalTrials.gov on 9 August 2019. Selection criteria: Randomized controlled trials (RCTs), quasi-randomized or non-randomized studies (cohort and case-control) comparing SSM to conventional mastectomy for treating ductal carcinoma in situ (DCIS) or invasive breast cancer. Data collection and analysis: We used standard methodological procedures expected by Cochrane. The primary outcome was overall survival. Secondary outcomes were local recurrence free-survival, adverse events (including overall complications, breast reconstruction loss, skin necrosis, infection and hemorrhage), cosmetic results, and quality of life. We performed a descriptive analysis and meta-analysis of the data. Main results: We found no RCTs or quasi-RCTs. We included two prospective cohort studies and twelve retrospective cohort studies. These studies included 12,211 participants involving 12,283 surgeries (3183 SSM and 9100 conventional mastectomies). It was not possible to perform a meta-analysis for overall survival and local recurrence free-survival due to clinical heterogeneity across studies and a lack of data to calculate hazard ratios (HR). Based on one study, the evidence suggests that SSM may not reduce overall survival for participants with DCIS tumors (HR 0.41, 95% CI 0.17 to 1.02; P = 0.06; 399 participants; very low-certainty evidence) or for participants with invasive carcinoma (HR 0.81, 95% CI 0.48 to 1.38; P = 0.44; 907 participants; very low-certainty evidence). For local recurrence-free survival, meta-analysis was not possible, due to high risk of bias in nine of the ten studies that measured this outcome. Informal visual examination of effect sizes from nine studies suggested the size of the HR may be similar between groups. Based on one study that adjusted for confounders, SSM may not reduce local recurrence-free survival (HR 0.82, 95% CI 0.47 to 1.42; P = 0.48; 5690 participants; very low-certainty evidence). The effect of SSM on overall complications is unclear (RR 1.55, 95% CI 0.97 to 2.46; P = 0.07, I2 = 88%; 4 studies, 677 participants; very low-certainty evidence). Skin-sparing mastectomy may not reduce the risk of breast reconstruction loss (RR 1.79, 95% CI 0.31 to 10.35; P = 0.52; 3 studies, 475 participants; very low-certainty evidence), skin necrosis (RR 1.15, 95% CI 0.62 to 2.12; P = 0.22, I2 = 33%; 4 studies, 677 participants; very low-certainty evidence), local infection (RR 2.04, 95% CI 0.03 to 142.71; P = 0.74, I2 = 88%; 2 studies, 371 participants; very low-certainty evidence), nor hemorrhage (RR 1.23, 95% CI 0.47 to 3.27; P = 0.67, I2 = 0%; 4 studies, 677 participants; very low-certainty evidence). We downgraded the certainty of the evidence due to the risk of bias, imprecision, and inconsistency among the studies. There were no data available on the following outcomes: systemic surgical complications, local complications, explantation of implant/expander, hematoma, seroma, rehospitalization, skin necrosis with revisional surgery, and capsular contracture of the implant. It was not possible to perform a meta-analysis for cosmetic and quality of life outcomes due to a lack of data. One study performed an evaluation of aesthetic outcome after SSM: 77.7% of participants with immediate breast reconstruction had an overall aesthetic result of excellent or good versus 87% of participants with delayed breast reconstruction. Authors' conclusions: Based on very low-certainty evidence from observational studies, it was not possible to draw definitive conclusions on the effectiveness and safety of SSM for breast cancer treatment. The decision for this technique of breast surgery for treatment of DCIS or invasive breast cancer must be individualized and shared between the physician and the patient while considering the potential risks and benefits of available surgical options.
Palavras-chave
Referências
  1. Carlson G.W., Bostwick J., Styblo T.M., Moore B., Bried J.T., Murray D.R., Et al., Skin-sparing mastectomy. Oncologic and reconstructive considerations, Annals of Surgery, 225, 5, pp. 570-578, (1997)
  2. Gerber B., Krause A., Dieterich M., Kundt G., Reimer T., The oncological safety of skin sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction: an extended follow-up study, Annals of Surgery, 249, 3, pp. 460-467, (2009)
  3. Giacalone P., Rathat G., Daures J., Benos P., Azria D., Rouleau C., New concept for immediate breast reconstruction for invasive cancers: feasibility, oncological safety and aesthetic outcome of post-neoadjuvant therapy immediate breast reconstruction versus delayed breast reconstruction: a prospective pilot study, Breast Cancer Research and Treatment, 122, 2, pp. 439-451, (2010)
  4. Greenway R.M., Schlossberg L., Dooley W.C., Fifteen-year series of skin-sparing mastectomy for stage 0 to 2 breast cancer, American Journal of Surgery, 190, 6, pp. 918-922, (2005)
  5. Kinoshita S., Nojima K., Takeishi M., Imawari Y., Kyoda S., Hirano A., Et al., Retrospective comparison of non-skin-sparing mastectomy and skin-sparing mastectomy with immediate breast reconstruction, International Journal of Surgical Oncology, 2011, pp. 1-9, (2011)
  6. Kroll S.S., Khoo A., Singletary E., Ames F., Wang B.G., Reece G., Et al., Local recurrence risk after skin-sparing and conventional mastectomy: a 6-year follow-up, Plastic and Reconstructive Surgery, 104, 2, pp. 421-425, (1999)
  7. Lee S.B., Lee J.W., Kim H.J., Ko B.S., Son B.H., Eom J.S., Et al., Long-term outcomes of patients with breast cancer after nipple-sparing mastectomy/skin sparing mastectomy followed by immediate transverse rectus abdominis musculocutaneous flap reconstruction, Medicine, 97, 18, (2018)
  8. Lee S.B., Lee J.W., Son B.H., Eom J.S., Kim E.K., Lee T.J., Et al., Oncologic safety of skin-sparing mastectomy followed by immediate reconstruction in young patients with breast cancer, Asian Journal of Surgery, 42, 1, pp. 274-282, (2019)
  9. Lhenaff M., Tunon de Lara C., Fournier M., Charitansky H., Brouste V., Mathoulin-Pelissier S., Et al., A single-center study on total mastectomy versus skin-sparing mastectomy in case of pure ductal carcinoma in situ of the breast, European Journal of Surgical Oncology, 45, 6, pp. 950-955, (2019)
  10. Lim W., Ko B.S., Kim H.J., Lee J.W., Eom J.S., Son B.H., Et al., Oncological safety of skin sparing mastectomy followed by immediate reconstruction for locally advanced breast cancer, Journal of Surgical Oncology, 102, 1, pp. 39-42, (2010)
  11. Yi M., Kronowitz S.J., Meric-Bernstam F., Feig B.W., Symmans W.F., Lucci A., Et al., Local, regional, and systemic recurrence rates in patients undergoing skin-sparing mastectomy compared with conventional mastectomy, Cancer, 117, 5, pp. 916-924, (2011)
  12. Prabhu R., Godette K., Carlson G., Losken A., Gabram S., Fasola C., Et al., The impact of skin-sparing mastectomy with immediate reconstruction in patients with Stage III breast cancer treated with neoadjuvant chemotherapy and postmastectomy radiation, International Journal of Radiation Oncology, Biology, Physics, 82, 4, pp. 587-593, (2011)
  13. Simmons R.M., Fish S.K., Gayle L., La Trenta G.S., Swistel A., Christos P., Et al., Local and distant recurrence rates in skin-sparing mastectomies compared with non-skin-sparing mastectomies, Annals of Surgical Oncology, 6, 7, pp. 676-681, (1999)
  14. Timbrell S., Al-Himdani S., Shaw O., Tan K., Morris J., Bundred N., Comparison of local recurrence after simple and skin-sparing mastectomy performed in patients with ductal carcinoma in situ, Annals of Surgical Oncology, 24, 4, pp. 1071-1076, (2017)
  15. Ueda S., Tamaki Y., Yano K., Okishiro N., Yanagisawa T., Imasato M., Et al., Cosmetic outcome and patient satisfaction after skin-sparing mastectomy for breast cancer with immediate reconstruction of the breast, Surgery, 143, 3, pp. 414-425, (2008)
  16. Park S.H., Han W., Yoo T.K., Lee H.B., Jin U.S., Chang H., Et al., Oncologic safety of immediate breast reconstruction for invasive breast cancer patients: a matched case control study, Journal of Breast Cancer, 19, 1, pp. 68-75, (2016)
  17. Al-Ghazal S.K., Fallowfield L., Blamey R.W., Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction, European Journal of Cancer, 36, pp. 1938-1943, (2000)
  18. Brierley J.D., Gospodarowicz M.K., Wittekind C., The TNM Classification of Malignant Tumours, (2017)
  19. Carlson G.W., Skin sparing mastectomy: anatomic and technical considerations, American Surgeon, 62, 2, pp. 151-155, (1996)
  20. Carlson G.W., Styblo T.M., Lyles R.H., Bostwick J., Murray D.R., Staley C.A., Et al., Local recurrence after skin-sparing mastectomy: tumor biology or surgical conservatism?, Annals of Surgical Oncology, 10, 2, pp. 108-112, (2003)
  21. Carlson G.W., Page A., Johnson E., Nicholson K., Styblo T.M., Wood W.C., Local recurrence of ductal carcinoma in situ after skin-sparing mastectomy, Journal of the American College of Surgeons, 204, 5, pp. 1074-1078, (2007)
  22. Cochran W.G., The combination of estimates from different experiments, Biometrics, 10, 1, pp. 101-129, (1954)
  23. Cochrane Effective Practice and Organisation of Care (EPOC) Group. Risk of bias, www.//epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/Suggested%20risk%20of%20bias%20criteria%20for%20EPOC%20reviews.pdf. (accessed 30 October 2013)
  24. Clinical aspects of sentinel node biopsy, Breast Cancer Research, 3, 2, pp. 104-108, (2001)
  25. Moher D., Schulz K.F., Altman D.G., The CONSORT Statement: revised recommendations for improving the quality of reports of parallel-group randomized trials, JAMA, 285, 15, pp. 1987-1991, (2001)
  26. Cunnick G.H., Mokbel K., Skin-sparing mastectomy, American Journal of Surgery, 188, 1, pp. 78-84, (2004)
  27. DerSimonian R., Laird N., Meta-analysis in clinical trials, Controlled Clinical Trials, 7, pp. 177-188, (1986)
  28. Fayers P.M., Aaronson N.K., Bjordal K., Groenvold M., Curran D., Bottomley A., European Organisation for Research and Treatment of Cancer, (1999)
  29. Giannotti D.G., Hanna S.A., Cerri G.G., Bevilacqua J.L., Analysis of skin flap thickness and residual breast tissue after mastectomy, International Journal of Radiation Oncology, Biology, Physics, 102, 1, pp. 82-91, (2018)
  30. Giuliano A.E., Jones R.C., Brennan M., Statman R., Sentinel lymphadenectomy in breast cancer, Journal of Clinical Oncology, 15, 6, pp. 2345-2350, (1997)
  31. Ferlay J., Colombet M., Soerjomataram I., Mathers C., Parkin D.M., Et al., Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods, International Agency for Research on Cancer. CancerBase No. 11 [Internet]. Available from www//globocan.iarc.fr
  32. Gordis L., Epidemiology, (1996)
  33. GRADEpro GDT
  34. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G., Measuring inconsistency in meta-analyses, BMJ, 327, pp. 557-560, (2003)
  35. Higgins J.P., Green S., Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011, Available from training.cochrane.org/handbook/archive/v5.1/
  36. Horiguchi J., Koibuchi Y., Yoshida T., Takata D., Kikuchi M., Rokutanda N., Et al., Significance of local recurrence as a prognostic factor in the treatment of breast cancer, Anticancer Research, 26, 1, pp. 569-573, (2006)
  37. Langstein H.N., Cheng M.H., Singletary S.E., Robb G.L., Hoy E., Smith T.L., Et al., Breast cancer recurrence after immediate reconstruction: patterns and significance, Plastic and Reconstructive Surgery, 111, 2, pp. 712-720, (2003)
  38. Lanitis S., Tekkis P.P., Sgourakis G., Dimopoulos N., Al Mufti R., Hadjiminas D.J., Comparison of skin-sparing mastectomy versus non-skin-sparing mastectomy for breast cancer: a meta-analysis of observational studies, Annals of Surgery, 251, 4, pp. 632-639, (2010)
  39. Lyman G.H., Giuliano A.E., Somerfield M.R., Bodurka D.C., Burstein H.J., Et al., American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer, Journal of Clinical Oncology, 23, 30, pp. 7703-7720, (2005)
  40. Madden J.L., Modified radical mastectomy, Surgery, Gynecology and Obstetrics, 121, 6, pp. 1221-1230, (1965)
  41. McKenzie J.E., Brennan S.E., Chapter 12: Synthesizing and presenting findings using other methods. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021, Available from training.cochrane.org/handbook
  42. Medina-Franco H., Vasconez L.O., Fix R.J., Heslin M.J., Beenken S.W., Bland K.I., Et al., Factors associated with local recurrence after skin-sparing mastectomy and immediate breast reconstruction for invasive breast cancer, Annals of Surgery, 235, 6, pp. 814-819, (2002)
  43. Morrow M., Strom E.A., Bassett L.W., Dershaw D.D., Fowble B., Giuliano A., Et al., Standard for breast conservation therapy in the management of invasive breast carcinoma, A Cancer Journal for Clinicians, 52, 5, pp. 277-300, (2002)
  44. Mota B.S., Riera R., Ricci M.D., Barrett J., de Castria T.B., Atallah A.N., Et al., Nipple- and areola-sparing mastectomy for the treatment of breast cancer, Cochrane Database of Systematic Reviews, 11, (2016)
  45. Newman L.A., Kuerer H.M., Hunt K.K., Kroll S.S., Ames F.C., Ross M.I., Et al., Presentation, treatment, and outcome of local recurrence after skin-sparing mastectomy and immediate breast reconstruction, Annals of Surgical Oncology, 5, 7, pp. 620-626, (1998)
  46. Norris S.L., Moher D., Reeves B.C., Shea B., Loke Y., Garner S., Et al., Issues relating to selective reporting when including non-randomized studies in systematic reviews on the effects of healthcare interventions, Research Synthesis Methods, 4, 1, pp. 36-47, (2013)
  47. Parmar M.K., Torri V., Stewart L., Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints, Statistics in Medicine, 17, 24, pp. 2815-2834, (1998)
  48. Patani N., Devalia H., Anderson A., Mokbel K., Oncological safety and patient satisfaction with skin-sparing mastectomy and immediate breast reconstruction, Surgical Oncology, 17, 2, pp. 97-105, (2008)
  49. Pusic A.L., Klassen A.F., Scott A.M., Klok J.A., Cordeiro P.G., Cano S.J., Development of a new patient-reported outcome measure for breast surgery: the BREAST-Q, Plastic and Reconstructive Surgery, 124, 2, pp. 345-353, (2009)
  50. Review Manager Web (RevMan web), (2020)
  51. Schunemann H.J., Oxman A.D., Higgins J.P., Vist G.E., Glasziou P., Guyatt G.H., Chapter 11: Presenting results and ‘Summary of findings' tables, In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011, Available from training.cochrane.org/handbook/archive/v5.1/
  52. Schunemann H., Oxman A.D., Vist G.E., Higgins J.P., Deeks J.J., Glasziou P., Et al., Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011, Available from training.cochrane.org/handbook/archive/v5.1/
  53. Singletary S.E., Robb G.L., Oncologic safety of skin-sparing mastectomy, Annals of Surgical Oncology, 10, 2, pp. 95-97, (2003)
  54. Slavin S.A., Schnitt S.J., Duda R.B., Houlihan M.J., Koufman C.N., Morris D.J., Et al., Skin-sparing mastectomy and immediate reconstruction: oncologic risks and aesthetic results in patients with early-stage breast cancer, Plastic and Reconstructive Surgery, 102, 1, pp. 49-62, (1998)
  55. Spiegel A.J., Butler C.E., Recurrence following treatment of ductal carcinoma in situ with skin-sparing mastectomy and immediate breast reconstruction, Plastic and Reconstructive Surgery, 111, 2, pp. 706-711, (2003)
  56. Tavassoli F.A., Devilee P., Pathology and Genetics of Tumours of the Breast and Female Genital Organs. World Health Organization Classification of Tumours, 4, (2003)
  57. Tierney J.F., Stewart L.A., Ghersi D., Burdett S., Sydes M.R., Practical methods for incorporating summary time-to-event data into meta-analysis, Trials, 8, (2007)
  58. Tokin C., Weiss A., Wang-Rodriguez J., Blair S.L., Oncologic safety of skin-sparing and nipple-sparing mastectomy: a discussion and review of the literature, International Journal of Surgical Oncology, 2012, pp. 921-929, (2012)
  59. Torresan R.Z., Dos Santos C.C., Brenelli H., Okamura H., Alvarenga M., Residual glandular tissue after skin-sparing mastectomies, Breast Journal, 11, 5, pp. 374-375, (2005)
  60. Torresan R.Z., Santos C.C.D., Okamura H., Al-Varenga M., Evaluation of residual glandular tissue after skin-sparing mastectomies, Annals of Surgical Oncology, 12, 12, pp. 1037-1044, (2005)
  61. Toth B.A., Lappert P., Modified skin incisions for mastectomy: the need for plastic surgical input in preoperative planning, Plastic and Reconstructive Surgery, 87, 6, pp. 1048-1053, (1991)
  62. Veronesi U., Salvadori B., Luini A., Banfi A., Zucali R., Del Vecchio M., Et al., Conservative treatment of early breast cancer. Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy, Annals of Surgery, 3, 211, pp. 250-259, (1990)
  63. von Elm E., Altman D.G., Egger M., Pocock S.J., Gotzsche P.C., Vandenbroucke J.P., The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies, Lancet, 370, 9596, pp. 1453-1457, (2007)
  64. Williamson P.R., Tudur Smith C., Hutton J.L., Marson A.G., Aggregate data meta-analysis with time-to-event outcomes, Statistics in Medicine, 21, pp. 3337-3351, (2002)